Yuyu Pharma (000220) — Cash Flow Quality Index
Yuyu Pharma (000220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩836.62 Million is below net income of ₩3.98 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Yuyu Pharma cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yuyu Pharma Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Yuyu Pharma across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 000220 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Yuyu Pharma (2011–2024)
Year-by-year earnings quality comparison for Yuyu Pharma. For live market cap and the full company financial profile, see how much is Yuyu Pharma worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.86x | ₩24.95 Billion | ₩8.72 Billion | ▲ +237.6% |
| 2020 | -2.08x | ₩-2.67 Billion | ₩1.28 Billion | ▼ -174.5% |
| 2019 | 2.79x | ₩13.19 Billion | ₩4.72 Billion | ▲ +83.7% |
| 2018 | 1.52x | ₩6.11 Billion | ₩4.02 Billion | ▲ +1584.3% |
| 2017 | 0.09x | ₩561.35 Million | ₩6.22 Billion | ▼ -94.6% |
| 2016 | 1.67x | ₩9.82 Billion | ₩5.89 Billion | ▲ +450.8% |
| 2013 | -0.48x | ₩-775.17 Million | ₩1.63 Billion | ▼ -120.1% |
| 2012 | 2.36x | ₩6.51 Billion | ₩2.76 Billion | ▼ -47.8% |
| 2011 | 4.52x | ₩6.67 Billion | ₩1.48 Billion | — |